SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kilitch Drugs forms JV in the Republic of Ethiopia with a local party

19 Oct 2015 Evaluate

Kilitch Drugs (India) has formed a joint venture (JV) in the Republic of Ethiopia with a local party therein to set up a pharmaceutical/ nutraceutical manufacturing unit whereby Kilitch Drugs (India) shall be a partner to the tune of 97% and the Ethiopian partner shall hold remaining 3% in the said joint venture.

Kilitch Drugs is a pharmaceutical company, its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms.

Kilitch Drugs(India) Share Price

185.30 2.95 (1.62%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: